SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech - Quaterly Results

25 May 2022 Evaluate
The revenue zoomed 11.88% to Rs. 227.54 millions for the quarter ended March 2022 as compared to Rs. 203.37 millions during the corresponding quarter last year.Net Profit of the company move down -33.57% to Rs. 27.53  millions from Rs. 41.44 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 53.15 millions from 54.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 227.54 203.37 11.88 1154.45 1101.46 4.81 1154.45 1101.46 4.81
Other Income 3.38 5.37 -37.06 17.20 7.54 128.12 17.20 7.54 128.12
PBIDT 53.15 54.19 -1.92 252.74 203.35 24.29 252.74 203.35 24.29
Interest 5.64 3.60 56.67 14.01 10.64 31.67 14.01 10.64 31.67
PBDT 47.51 50.59 -6.09 238.73 192.71 23.88 238.73 192.71 23.88
Depreciation 15.24 4.15 267.23 57.71 25.20 129.01 57.71 25.20 129.01
PBT 32.27 46.44 -30.51 181.02 167.51 8.07 181.02 167.51 8.07
TAX 4.74 5.00 -5.20 31.97 42.65 -25.04 31.97 42.65 -25.04
Deferred Tax -0.61 0.50 -222.00 -7.80 1.19 -755.46 -7.80 1.19 -755.46
PAT 27.53 41.44 -33.57 149.05 124.86 19.37 149.05 124.86 19.37
Equity 122.17 122.17 0.00 122.17 122.17 0.00 122.17 122.17 0.00
PBIDTM(%) 23.36 26.65 -12.34 21.89 18.46 18.58 21.89 18.46 18.58

Medicamen Biotech Share Price

224.25 -0.20 (-0.09%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: